Curosurf 240 MG/3 ML vial 3ML
Ended Awarded
- Contract number
- SPE2DB26FP7JZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,439
Award facts
- Contract value 100% obligated
- $1,438.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,438.56 to AmerisourceBergen Drug Corp for CUROSURF 240 MG/3 ML vials on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. CUROSURF is a pulmonary surfactant medication used primarily in neonatal critical care for respiratory distress syndrome. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters.
This delivery order is a child contract under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA Troop Support Medical, which authorizes the company to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies. AmerisourceBergen, as a major pharmaceutical distributor and a critical vendor within the federal medical procurement ecosystem, has demonstrated sustained capability through multiple competitively awarded contracts across the Defense Logistics Agency's medical supply chain. The award continues the company's role as a key supplier for Department of Defense and veteran healthcare system pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB26FP7JZ?
SPE2DB26FP7JZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FP7JZ worth?
The government has obligated $1,439 on SPE2DB26FP7JZ.
Is contract SPE2DB26FP7JZ an order under another contract?
Yes. SPE2DB26FP7JZ is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB26FP7JZ competed?
The extent of competition for SPE2DB26FP7JZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award